Victor Moreno

51PUBLICATIONS

367CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|Jun 19, 2026

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Jun 09, 2026

A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|May 01, 2026

Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.

|Apr 21, 2026

Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Apr 20, 2026

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.

|Apr 09, 2026

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.

Jose Luis Perez-Gracia, Begoña Mellado, Aaron Richard Hansen

Pageof 9

Frequent Collaborators

13 joint publications

Emiliano Calvo Aller

8 joint publications

Tatiana Hernandez-Guerrero

Ignacio Melero

Giuseppe Curigliano

Elena Garralda

Maria José De Miguel

Antoine Italiano

Kristoffer Staal Rohrberg

3 joint publications

Alexander Drilon

3 joint publications

Chia-Chi Lin

Frequent Collaborators

13 joint publications

Emiliano Calvo Aller

8 joint publications

Tatiana Hernandez-Guerrero

7 joint publications

Ignacio Melero

4 joint publications

Giuseppe Curigliano